Genitourinary Cancers — 5-Minute Journal Club Issue 2 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

About this episode

Professor Thomas Powles discusses the role of circulating tumor DNA assays in managing urothelial bladder cancer.

Professor Thomas Powles from Barts Cancer Institute in London, United Kingdom, discusses recent developments with circulating tumor DNA assays in the management of urothelial bladder cancer. CME information and select publications

People in this episode

Host: Dr. Neil Love

Guest: Professor Thomas Powles

Topics covered

• genitourinary cancers
• circulating tumor DNA
• urothelial bladder cancer
• tumor-informed assays
• cancer management

Keywords

• circulating tumor DNA
• urothelial bladder cancer
• cancer management
• tumor-informed assays
• CME information

Mentioned in this episode

Organizations: Barts Cancer Institute

Places: London, United Kingdom

More episodes of Prostate Cancer Update

• Localized Renal Cell Carcinoma — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting · June 12, 2026 · 1h 29m
• Genitourinary Cancers — 5-Minute Journal Club Issue 1 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays · May 26, 2026 · 30 min
• PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida · May 15, 2026 · 52 min
• Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances · April 17, 2026 · 58 min
• Metastatic Bladder Cancer — Rapid Case Review Issue 4 · April 15, 2026 · 28 min
• AKT Inhibition in Prostate Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium · March 31, 2026 · 1h 29m